159 related articles for article (PubMed ID: 22530069)
1. Stereoselective regulations of P-glycoprotein by ginsenoside Rh2 epimers and the potential mechanisms from the view of pharmacokinetics.
Zhang J; Zhou F; Niu F; Lu M; Wu X; Sun J; Wang G
PLoS One; 2012; 7(4):e35768. PubMed ID: 22530069
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective property of 20(S)-protopanaxadiol ocotillol type epimers affects its absorption and also the inhibition of P-glycoprotein.
Wang W; Wu X; Wang L; Meng Q; Liu W
PLoS One; 2014; 9(6):e98887. PubMed ID: 24887182
[TBL] [Abstract][Full Text] [Related]
3. 20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: a case for herb-drug interactions.
Zhang J; Zhou F; Wu X; Gu Y; Ai H; Zheng Y; Li Y; Zhang X; Hao G; Sun J; Peng Y; Wang G
Drug Metab Dispos; 2010 Dec; 38(12):2179-87. PubMed ID: 20837659
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective pharmacokinetic and metabolism studies of 20(S)- and 20(R)-ginsenoside Rg₃ epimers in rat plasma by liquid chromatography-electrospray ionization mass spectrometry.
Peng M; Li X; Zhang T; Ding Y; Yi Y; Le J; Yang Y; Chen X
J Pharm Biomed Anal; 2016 Mar; 121():215-224. PubMed ID: 26826673
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interactions between 20(S)-ginsenoside Rh2 and the HIV protease inhibitor ritonavir in vitro and in vivo.
Shi J; Cao B; Zha WB; Wu XL; Liu LS; Xiao WJ; Gu RR; Sun RB; Yu XY; Zheng T; Li MJ; Wang XW; Zhou J; Mao Y; Ge C; Ma T; Xia WJ; Aa JY; Wang GJ; Liu CX
Acta Pharmacol Sin; 2013 Oct; 34(10):1349-58. PubMed ID: 23892274
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and tissue distribution of ginsenoside Rh2 and Rg3 epimers after oral administration of BST204, a purified ginseng dry extract, in rats.
Bae SH; Park JB; Zheng YF; Jang MJ; Kim SO; Kim JY; Yoo YH; Yoon KD; Oh E; Bae SK
Xenobiotica; 2014 Dec; 44(12):1099-107. PubMed ID: 24933530
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in silico evaluation of stereoselective effect of ginsenoside isomers on platelet P2Y
Yang Q; Wang N; Zhang J; Chen G; Xu H; Meng Q; Du Y; Yang X; Fan H
Phytomedicine; 2019 Nov; 64():152899. PubMed ID: 31454649
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective pharmacokinetics of 25-methoxyl-dammarane-3β,12β,20-triol and its active demethyl-metabolite epimers in rats after oral and intravenous administration.
Shao N; Jiang H; Wang X; Yuan B; Jin Y; Song M; Zhao Y; Xu H
Fitoterapia; 2017 Jan; 116():139-145. PubMed ID: 27940119
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of oral bioavailability of 20(S)-ginsenoside Rh2 through improved understanding of its absorption and efflux mechanisms.
Yang Z; Gao S; Wang J; Yin T; Teng Y; Wu B; You M; Jiang Z; Hu M
Drug Metab Dispos; 2011 Oct; 39(10):1866-72. PubMed ID: 21757611
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of self-microemulsions for improved bioavailability of ginsenoside-Rh1 and Rh2.
Yang F; Zhou J; Hu X; Yu SK; Liu C; Pan R; Chang Q; Liu X; Liao Y
Drug Deliv Transl Res; 2017 Oct; 7(5):731-737. PubMed ID: 28677033
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective determination of ginsenosides Rg3 and Rh2 epimers in rat plasma by LC-MS/MS: application to a pharmacokinetic study.
Bae SH; Zheng YF; Yoo YH; Kim JY; Kim SO; Jang MJ; Seo JH; Bae SK
J Sep Sci; 2013 Jun; 36(12):1904-12. PubMed ID: 23559579
[TBL] [Abstract][Full Text] [Related]
12. Ginseng polysaccharides enhanced ginsenoside Rb1 and microbial metabolites exposure through enhancing intestinal absorption and affecting gut microbial metabolism.
Shen H; Gao XJ; Li T; Jing WH; Han BL; Jia YM; Hu N; Yan ZX; Li SL; Yan R
J Ethnopharmacol; 2018 Apr; 216():47-56. PubMed ID: 29366768
[TBL] [Abstract][Full Text] [Related]
13. Intestinal absorption mechanisms of ginsenoside Rh2: stereoselectivity and involvement of ABC transporters.
Gu Y; Wang GJ; Wu XL; Zheng YT; Zhang JW; Ai H; Sun JG; Jia YW
Xenobiotica; 2010 Sep; 40(9):602-12. PubMed ID: 20608841
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of oral bioavailability and immune response of Ginsenoside Rh2 by co-administration with piperine.
Jin ZH; Qiu W; Liu H; Jiang XH; Wang L
Chin J Nat Med; 2018 Feb; 16(2):143-149. PubMed ID: 29455730
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: herb-drug interactions mediated via P-gp.
Li X; Hu J; Wang B; Sheng L; Liu Z; Yang S; Li Y
Toxicol Appl Pharmacol; 2014 Mar; 275(2):163-75. PubMed ID: 24380838
[TBL] [Abstract][Full Text] [Related]
16. Skin anti-photoaging properties of ginsenoside Rh2 epimers in UV-B-irradiated human keratinocyte cells.
Oh SJ; Lee S; Choi WY; Lim CJ
J Biosci; 2014 Sep; 39(4):673-82. PubMed ID: 25116621
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside metabolites inhibit P-glycoprotein in vitro and in situ using three absorption models.
Li N; Wang D; Ge G; Wang X; Liu Y; Yang L
Planta Med; 2014 Mar; 80(4):290-6. PubMed ID: 24493631
[TBL] [Abstract][Full Text] [Related]
18. Differential antiangiogenic and anticancer activities of the active metabolites of ginsenoside Rg3.
Nakhjavani M; Smith E; Yeo K; Tomita Y; Price TJ; Yool A; Townsend AR; Hardingham JE
J Ginseng Res; 2024 Mar; 48(2):171-180. PubMed ID: 38465222
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-Based Pharmacokinetic Model for the Deglycosylation Kinetics of 20(S)-Ginsenosides Rh2.
Ren HC; Sun JG; A JY; Gu SH; Shi J; Shao F; Ai H; Zhang JW; Peng Y; Yan B; Huang Q; Liu LS; Sai Y; Wang GJ; Yang CG
Front Pharmacol; 2022; 13():804377. PubMed ID: 35694247
[No Abstract] [Full Text] [Related]
20. Stereoisomer-specific anticancer activities of ginsenoside Rg3 and Rh2 in HepG2 cells: disparity in cytotoxicity and autophagy-inducing effects due to 20(S)-epimers.
Cheong JH; Kim H; Hong MJ; Yang MH; Kim JW; Yoo H; Yang H; Park JH; Sung SH; Kim HP; Kim J
Biol Pharm Bull; 2015; 38(1):102-8. PubMed ID: 25744465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
